Business · 30/10/2015Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products
Summary
The FDA has published a draft document outlining recommendations for applying the 'homologous use' criterion to human cells, tissues, and cellular and tissue-based products, in an effort to clarify the interpretation and application of this criterion for industry stakeholders.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →